arrow
J

Jérôme Durivault

Scientific Centre of Monaco
H指数:18
被引数:1,955

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer

结缔组织生长因子导致肾癌对血管生成抑制治疗的耐药性

2026-01-010
PRE
Comparative theranostic efficacy of 177Lu- and 161Tb-labeled A1K2 SdAb in mesothelin-positive tumors

177Lu和161Tb标记的A1K2 SdAb在间皮素阳性肿瘤中的比较诊疗效果

2025-12-270
OAAI
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model

靶向黑色素瘤转移灶的黑色素异质性:一种双肿瘤小鼠黑色素瘤模型

2025-09-020
OAAI
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001
2024-03-196
OAAI
Neuropilin 1 and Neuropilin 2 gene invalidation or pharmacological inhibition reveals their relevance for the treatment of metastatic renal cell carcinoma
2021-01-1812
OAAI
VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells

VEGFC负调控髓母细胞瘤细胞的生长和侵袭性

2020-10-1611
OAAI
VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

VEGFC在肾细胞癌侵袭性中起着双刃剑的作用

2019-01-0123
OAAI
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the Warburg effect restricting tumor growth to oxidative metabolism

需要乳酸脱氢酶A和B的双重遗传破坏来消除Warburg效应,从而将肿瘤生长限制为氧化代谢

2018-10-01201
OAAI